Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.1M | 23.9M | 21.7M | 27.6M |
Cost of revenue | 3.3M | 4.2M | 3.1M | 3.1M |
Gross profit | 13.8M | 19.6M | 18.6M | 24.5M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 2.5M | 2.3M | 2.3M | 2.5M |
Operating income | 10.5M | 15.5M | 14.1M | 19.6M |
Non operating interest income | ||||
Income | 2K | 47K | 6K | 15K |
Expense | 764K | 253K | 20K | 27K |
Other income expense | — | — | — | — |
Pretax income | 12.5M | 14.9M | 15.9M | 4.5M |
Tax provision | 2.2M | 3.7M | 3.8M | 4.3M |
Net income | 10.3M | 11.2M | 12.0M | 230K |
Basic EPS | 0.3 | 0.3 | 0.4 | 0.0 |
Diluted EPS | 0.3 | 0.3 | 0.4 | 0.0 |
Basic average shares | 34.0M | 34.0M | 34.0M | 34.0M |
Diluted average shares | 34.0M | 34.0M | 34.0M | 34.0M |
EBITDA | 10.5M | 16.1M | 17.0M | 20.7M |
Net income from continuing op. | 13.2M | 10.9M | 12.0M | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |